海利生物
(603718)
| 流通市值：48.28亿 | | | 总市值：48.78亿 |
| 流通股本：6.49亿 | | | 总股本：6.56亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 362,243,931.99 | 358,503,504.83 | 77,525,211.08 | 37,207,690.91 |
| 应收票据及应收账款 | 126,856,127.76 | 108,965,294.39 | 90,817,823.18 | 85,339,472.73 |
| 其中：应收票据 | 1,743,295 | 543,195 | 614,960 | 460,750 |
| 应收账款 | 125,112,832.76 | 108,422,099.39 | 90,202,863.18 | 84,878,722.73 |
| 预付款项 | 3,665,987.23 | 2,818,692.69 | 7,710,601.77 | 5,643,955.3 |
| 其他应收款合计 | 3,048,359.18 | 2,924,158.3 | 106,479,598.61 | 8,900,735.94 |
| 存货 | 57,751,030.62 | 55,008,874.54 | 84,788,878.06 | 102,807,986.79 |
| 其他流动资产 | 11,238,433.34 | 4,972,944.33 | 11,650,861.07 | - |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 678,355,838.27 | 691,774,180.51 | 1,169,792,575.23 | 523,376,933.68 |
| 非流动资产: | | | | |
| 长期股权投资 | - | - | - | 628,695,663.65 |
| 其他非流动金融资产 | - | - | 12,902,809.16 | 12,902,809.16 |
| 固定资产 | 29,844,251.25 | 29,045,175.02 | 147,905,610.66 | 152,797,934.48 |
| 在建工程 | 21,061,557.84 | 12,717,404.34 | 754,300.97 | 754,300.97 |
| 使用权资产 | 18,012,035.54 | 18,837,832.91 | 4,403,362.23 | 283,451.64 |
| 无形资产 | 56,227,999 | 55,581,246.07 | 28,637,406.59 | 31,792,293.56 |
| 商誉 | 1,019,645,700.98 | 1,005,705,419.88 | 225,330,348.7 | 225,330,348.7 |
| 长期待摊费用 | 6,901,476.52 | 5,918,029.95 | 8,099,813.55 | 8,467,521.82 |
| 递延所得税资产 | 734,688.06 | 736,020.86 | 21,709,942.01 | 14,361,127.09 |
| 其他非流动资产 | 2,539,000 | 6,523,910 | 4,179,500 | 4,387,350 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,154,966,709.19 | 1,135,065,039.03 | 453,923,093.87 | 1,079,772,801.07 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,833,322,547.46 | 1,826,839,219.54 | 1,623,715,669.1 | 1,603,149,734.75 |
| 流动负债: | | | | |
| 短期借款 | - | - | 60,913,429 | 61,500,000 |
| 应付票据及应付账款 | 9,634,642.13 | 8,795,466.25 | 21,876,109.83 | 23,039,137.64 |
| 应付账款 | 9,634,642.13 | 8,795,466.25 | 21,876,109.83 | 23,039,137.64 |
| 合同负债 | 10,346,048.79 | 9,808,394.05 | 3,428,244.66 | 18,793,656.31 |
| 应付职工薪酬 | 12,944,408.34 | 17,897,696.21 | 3,552,913.92 | 3,372,701.36 |
| 应交税费 | 6,976,093.44 | 11,811,318.93 | 1,490,744.6 | 1,728,936.65 |
| 其他应付款合计 | 39,943,918.84 | 48,269,483.41 | 279,679,100.09 | 262,369,881.99 |
| 一年内到期的非流动负债 | 2,602,841.5 | 3,660,562.74 | - | 48,085.06 |
| 其他流动负债 | 21,663.27 | 3,537.75 | 102,847.34 | 563,809.69 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 82,469,616.31 | 100,246,459.34 | 371,043,389.44 | 371,416,208.7 |
| 非流动负债: | | | | |
| 租赁负债 | 14,157,190.1 | 13,936,850.36 | 4,074,606.31 | - |
| 递延收益 | - | - | 20,737,485.28 | 21,160,985.26 |
| 递延所得税负债 | 9,894,225.94 | 9,462,422.08 | 2,190,089.48 | 1,418,480.71 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 24,051,416.04 | 23,399,272.44 | 27,002,181.07 | 22,579,465.97 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 106,521,032.35 | 123,645,731.78 | 398,045,570.51 | 393,995,674.67 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 655,662,200 | 657,900,000 | 657,900,000 | 657,900,000 |
| 资本公积 | 279,135,088.74 | 281,859,046.69 | 282,310,065.09 | 262,574,714.63 |
| 减:库存股 | 31,750,562.25 | 42,383,021.39 | 66,043,070 | 66,442,000 |
| 其他综合收益 | - | - | -1,002,592.53 | -11,474,733.62 |
| 盈余公积 | 107,480,336.81 | 106,390,165.3 | 91,289,475.37 | 90,784,631.47 |
| 未分配利润 | 566,523,735.75 | 556,712,192.16 | 308,408,915.3 | 322,747,050.2 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,577,050,799.05 | 1,560,478,382.76 | 1,272,862,793.23 | 1,256,089,662.68 |
| 少数股东权益 | 149,750,716.06 | 142,715,105 | -47,192,694.64 | -46,935,602.6 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,726,801,515.11 | 1,703,193,487.76 | 1,225,670,098.59 | 1,209,154,060.08 |
| 负债和股东权益合计 | 1,833,322,547.46 | 1,826,839,219.54 | 1,623,715,669.1 | 1,603,149,734.75 |
| 公告日期 | 2025-04-22 | 2025-04-22 | 2024-10-31 | 2024-08-31 |
| 审计意见(境内) | | 标准无保留意见 | | |